Bleeding on HRT: Expected Early, Checked If Late
SaveSpotting in the first 3 to 6 months of continuous hormone therapy is expected as the lining adjusts. Bleeding that lasts beyond about 6 months, or returns after months of none, is worth checking — usually benign, but evaluation rules out endometrial causes. A transvaginal ultrasound or biopsy may be part of that assessment.
Last updated: July 2026
Is spotting on HRT normal at first?
Unscheduled spotting is one of the most common early effects of continuous hormone therapy, reported by many people in the first months 2Ref 2The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Bleeding patterns on continuous versus sequential regimens, the endometrial-protective role of the progestogen, and benign causes of breakthrough bleeding.. The uterine lining takes time to adjust to steady estrogen and progestogen, and light, irregular bleeding during that settling period is expected rather than alarming 1Ref 1National Institute for Health and Care Excellence (2026).Menopause: identification and management (NG23).Guidance that unscheduled bleeding persisting beyond the early months of HRT, or starting after a bleed-free period, warrants assessment, and that bleeding patterns depend on the regimen.. According to the North American Menopause Society, bleeding patterns depend heavily on the regimen: continuous combined therapy often causes early spotting that fades, while sequential therapy is designed to produce a scheduled monthly bleed 2Ref 2The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Bleeding patterns on continuous versus sequential regimens, the endometrial-protective role of the progestogen, and benign causes of breakthrough bleeding.. In perimenopause, irregular bleeding is expected anyway as cycles wind down, so spotting is read differently than in someone years past her final period 1Ref 1National Institute for Health and Care Excellence (2026).Menopause: identification and management (NG23).Guidance that unscheduled bleeding persisting beyond the early months of HRT, or starting after a bleed-free period, warrants assessment, and that bleeding patterns depend on the regimen.. Tracking when bleeding happens, alongside other menopause symptoms, helps a clinician interpret it.
When does bleeding on HRT need checking?
Bleeding earns a closer look once it falls outside the expected early window. Guidelines generally treat unscheduled bleeding that persists beyond about 6 months of continuous therapy — or that begins after a stretch of no bleeding — as a reason to be assessed 1Ref 1National Institute for Health and Care Excellence (2026).Menopause: identification and management (NG23).Guidance that unscheduled bleeding persisting beyond the early months of HRT, or starting after a bleed-free period, warrants assessment, and that bleeding patterns depend on the regimen.. According to NICE, the timing and pattern of bleeding guide whether and how quickly to investigate 1Ref 1National Institute for Health and Care Excellence (2026).Menopause: identification and management (NG23).Guidance that unscheduled bleeding persisting beyond the early months of HRT, or starting after a bleed-free period, warrants assessment, and that bleeding patterns depend on the regimen.. The concern is not that bleeding usually signals cancer; most cases have a benign cause such as lining adjustment, a missed dose, or absorption changes 2Ref 2The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Bleeding patterns on continuous versus sequential regimens, the endometrial-protective role of the progestogen, and benign causes of breakthrough bleeding.. Because unscheduled bleeding can occasionally be the first sign of endometrial hyperplasia or cancer, checking is how clinicians rule that out early 3Ref 3National Cancer Institute (PDQ Adult Treatment Editorial Board) (2020).Endometrial Cancer Treatment (PDQ®)–Patient Version.Abnormal or postmenopausal bleeding as the most common symptom prompting evaluation for endometrial hyperplasia and cancer, assessed by transvaginal ultrasound and endometrial biopsy..
What does an evaluation for bleeding involve?
An evaluation for unscheduled bleeding is usually quick and focused. A clinician typically starts with your history and a pelvic examination, then may arrange a transvaginal ultrasound to measure the thickness of the uterine lining 3Ref 3National Cancer Institute (PDQ Adult Treatment Editorial Board) (2020).Endometrial Cancer Treatment (PDQ®)–Patient Version.Abnormal or postmenopausal bleeding as the most common symptom prompting evaluation for endometrial hyperplasia and cancer, assessed by transvaginal ultrasound and endometrial biopsy.. If the lining is thickened or the picture is unclear, an endometrial biopsy — a small sample taken in the office — can check the cells directly 3Ref 3National Cancer Institute (PDQ Adult Treatment Editorial Board) (2020).Endometrial Cancer Treatment (PDQ®)–Patient Version.Abnormal or postmenopausal bleeding as the most common symptom prompting evaluation for endometrial hyperplasia and cancer, assessed by transvaginal ultrasound and endometrial biopsy.. According to the National Cancer Institute, abnormal or postmenopausal bleeding is the most common symptom that prompts evaluation for endometrial cancer, which is why it is not ignored 3Ref 3National Cancer Institute (PDQ Adult Treatment Editorial Board) (2020).Endometrial Cancer Treatment (PDQ®)–Patient Version.Abnormal or postmenopausal bleeding as the most common symptom prompting evaluation for endometrial hyperplasia and cancer, assessed by transvaginal ultrasound and endometrial biopsy.. Reviewing the regimen itself, including dose and how consistently it is used, is often part of the same visit 2Ref 2The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Bleeding patterns on continuous versus sequential regimens, the endometrial-protective role of the progestogen, and benign causes of breakthrough bleeding..
How does your HRT regimen affect bleeding?
The bleeding you can expect depends on which regimen you use. Sequential (cyclical) therapy, often chosen in perimenopause, deliberately produces a predictable monthly withdrawal bleed 1Ref 1National Institute for Health and Care Excellence (2026).Menopause: identification and management (NG23).Guidance that unscheduled bleeding persisting beyond the early months of HRT, or starting after a bleed-free period, warrants assessment, and that bleeding patterns depend on the regimen.. Continuous combined therapy, more common after menopause, aims for no bleeding at all once the lining settles, usually within 3 to 6 months 1Ref 1National Institute for Health and Care Excellence (2026).Menopause: identification and management (NG23).Guidance that unscheduled bleeding persisting beyond the early months of HRT, or starting after a bleed-free period, warrants assessment, and that bleeding patterns depend on the regimen.. Switching between regimens, changing the progestogen, or missing doses can each restart spotting 2Ref 2The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Bleeding patterns on continuous versus sequential regimens, the endometrial-protective role of the progestogen, and benign causes of breakthrough bleeding.. The North American Menopause Society notes that the progestogen component is what protects the lining, so a change in bleeding is sometimes a signal to review that part of the plan 1Ref 1National Institute for Health and Care Excellence (2026).Menopause: identification and management (NG23).Guidance that unscheduled bleeding persisting beyond the early months of HRT, or starting after a bleed-free period, warrants assessment, and that bleeding patterns depend on the regimen.. A hormone therapy review can match the regimen to your stage and goals.
When bleeding on HRT needs a gynecologist
A clinician can distinguish expected settling from bleeding that deserves a workup. Someone tracking new or persistent bleeding — especially after months of none — benefits from an assessment that checks the lining and reviews the regimen together 1Ref 1National Institute for Health and Care Excellence (2026).Menopause: identification and management (NG23).Guidance that unscheduled bleeding persisting beyond the early months of HRT, or starting after a bleed-free period, warrants assessment, and that bleeding patterns depend on the regimen.. A gynecologist or menopause-experienced clinician can order the right test and adjust therapy if bleeding reflects the dose or progestogen rather than anything worrying 3Ref 3National Cancer Institute (PDQ Adult Treatment Editorial Board) (2020).Endometrial Cancer Treatment (PDQ®)–Patient Version.Abnormal or postmenopausal bleeding as the most common symptom prompting evaluation for endometrial hyperplasia and cancer, assessed by transvaginal ultrasound and endometrial biopsy.. Understanding how irregular perimenopausal bleeding and the wider perimenopausal transition shape what is normal can make that visit more useful. Gale can help you prepare for that conversation.
Common questions
Related
Menopause & midlife
Early HRT Side Effects: What Settles, What Doesn'tMenopause & midlife
Starting HRT After 60: The Timing QuestionMenopause & midlife
Perimenopause With Regular Periods: Yes, It Happens
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When bleeding on HRT needs assessment
- —Unscheduled bleeding that lasts beyond about 6 months of continuous therapy, or begins after months of none, is a reason to arrange evaluation.
- —Any bleeding after a clear postmenopausal, bleed-free stretch is a reason to seek clinician review.
- —Heavy bleeding that soaks through protection, or bleeding with dizziness or feeling faint, is a reason to seek urgent medical care.
- —New pelvic pain, or bleeding with a change in vaginal discharge, is a reason to contact your clinician.
This article is general health education, not medical advice. Whether bleeding on hormone therapy needs testing or a change in regimen is a decision to make with a gynecologist or a menopause-experienced clinician.
References
- 1.National Institute for Health and Care Excellence (2026). Menopause: identification and management (NG23). National Institute for Health and Care Excellence (NICE). link ✓Guidance that unscheduled bleeding persisting beyond the early months of HRT, or starting after a bleed-free period, warrants assessment, and that bleeding patterns depend on the regimen.
- 2.The North American Menopause Society (Menopause Society) (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000002028 ✓Bleeding patterns on continuous versus sequential regimens, the endometrial-protective role of the progestogen, and benign causes of breakthrough bleeding.
- 3.National Cancer Institute (PDQ Adult Treatment Editorial Board) (2020). Endometrial Cancer Treatment (PDQ®)–Patient Version. National Cancer Institute (NCI), NIH. link ✓Abnormal or postmenopausal bleeding as the most common symptom prompting evaluation for endometrial hyperplasia and cancer, assessed by transvaginal ultrasound and endometrial biopsy.
3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy